Hamlet Pharma is a pharmaceutical company. Most research and development is carried out in the field of protein-lipid complexes, which are used in the treatment of various forms of cancer. The company has developed a tumoricidal protein-lipid complex that mainly is used in the treatment of breast cancer, bladder cancer, as well as in cases of cancer that are hard to treat. The company is based in Lund.

Quotes for Hamlet Pharma AB

Right Now

+/-
-0.5
%
-2,20%
Latest
22.2
High
23.5
Low
22.2
Volume
43 108
Turnover (SEK)
982 514
Value (MSEK)
746,5

Board

CEO

  • Mats Persson

Chairman Of The Board

  • Catharina Svanborg

Board

  • Bengt Westermark
  • Christer Köhler
  • Helena Lomberg

Videos

Largest Owners

Name Capital % Votes % Date
Catharina Svanborg 50,19 50,19 2020-09-30
Nordnet Pensionsförsäkring 7,55 7,55 2020-09-30
Avanza Pension 4,24 4,24 2020-09-30
FV Group AB 1,78 1,78 2020-09-30
Hans Nygren 1,64 1,64 2020-09-30
Fredrik Herslow 1,10 1,10 2020-09-30
Livförsäkringsbolaget Skandia 0,80 0,80 2020-09-30
Olle Jönsson 0,62 0,62 2020-09-30
Swedbank Försäkring 0,54 0,54 2020-09-30
Daniel Åberg 0,30 0,30 2020-09-30
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2020-11-26 Årsstämma 2020

  • 2021-02-26 Delårsrapport 2021-Q2

  • 2021-05-21 Delårsrapport 2021-Q3

  • 2021-08-27 Bokslutskommuniké 2021

  • 2021-11-11 Delårsrapport 2022-Q1

  • 2021-11-25 Årsstämma 2021